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Internal ribosome entry site (IRES)
RNA secondary structure
Poly(rC)-binding protein (PCBP)Coxsackievirus B3 (CVB3) is a causative agent of viral myocarditis, meningitis, pancreatitis, and encephalitis.
Much of what is known about the coxsackievirus intracellular replication cycle is based on the information
already known from a well-studied and closely related virus, poliovirus. Like that of poliovirus, the 5′
noncoding region (5′ NCR) of CVB3 genomic RNA contains secondary structures that function in both viral
RNA replication and cap-independent translation initiation. For poliovirus IRES-mediated translation, the
interaction of the cellular protein PCBP2 with a major secondary structure element (stem-loop IV) is required
for gene expression. Previously, the complete secondary structure of the coxsackievirus 5′ NCR was
determined by chemical structure probing and overall, many of the RNA secondary structures bear signiﬁcant
similarity to those of poliovirus; however, the functions of the coxsackievirus IRES stem-loop structures have
not been determined. Here we report that a CVB3 RNA secondary structure, stem-loop IV, folds similarly to
poliovirus stem-loop IV and like its enterovirus counterpart, coxsackievirus stem-loop IV interacts with
PCBP2. We used RNase foot-printing to identify RNA sequences protected following PCBP2 binding to
coxsackievirus stem-loop IV. When nucleotide substitutions were separately engineered at two sites in
coxsackievirus stem-loop IV to reduce PCBP2 binding, inhibition of IRES-mediated translation was observed.
Both of these nucleotide substitutions were engineered into full-length CVB3 RNA and upon transfection into
HeLa cells, the speciﬁc infectivities of both constructs were reduced and the recovered viruses displayed
small-plaque phenotypes and slower growth kinetics compared to wild type virus.© 2009 Elsevier Inc. All rights reserved.IntroductionCoxsackievirus B3 (CVB3) is a member of the enterovirus genus in
the family Picornaviridae. CVB3 infection of heart cells leads to
cardiomyopathies (Beck et al., 1990; Esfandiarei and McManus, 2008).
In a mouse model, cardiovirulence of coxsackievirus was demonstrated
by extensive inﬂammatory lesions and necrosis of heart tissue (Tracy
et al., 1992; for review see Kim et al., 2001). Like other picornaviruses,
coxsackievirus has a single-stranded, positive-sense RNA genome
encapsidated by proteins that form an icosahedron of approximately
28 nm (Crowell and Landau, 1997). Two integral membrane receptors
have been identiﬁed for viral entry, coxsackievirus and adenovirus
receptor (CAR) (Bergelson et al., 1997) and CD55, a decay-accelerating
factor (DAF) (Shafren et al., 1995). Once inside the cell, coxsackievirus
completes its replication cycle in the cytoplasm.
Like that of poliovirus, a closely-related picornavirus, the
coxsackievirus genome has a long stretch of noncoding sequenceoodman Cancer Centre, McGill
ll rights reserved.(5′ NCR) upstream of the authentic start codon. The ∼740-nucleotide
5′ NCR (Lindberg et al., 1987) is highly structured, containing multiple
stem-loop elements (Yang et al., 1997; Bailey and Tapprich, 2007).
Unlike cellular messenger RNAs, translation of picornavirus genomes
occurs via a cap-independent pathway. In the canonical mechanism of
cap-dependent translation initiation, the 5′ cap on cellular mRNAs is
recognized by the eIF4F cap-binding complex, which results in the
recruitment of ribosomes (Merrick, 1990); however, picornaviruses
lack the 7-methyl G cap structure and instead have a viral protein
(VPg) that is covalently linked to the 5′ terminus of the genome (Lee
et al., 1977; Flanegan et al., 1977). Also, during an enterovirus
infection, the virus-encoded proteinase 2A cleaves eIF4G to disrupt
the cap-binding complex (Etchison et al., 1982; Krausslich et al., 1987).
Thus, the cleavage of eIF4G acts to inhibit eIF4F-mediated ribosome
scanning in cap-dependent translation. Without a 5′ cap to initiate
cap-recognition and ribosome scanning, picornaviruses utilize an
alternative, internal pathway for translation initiation. The RNA
secondary structures that form within the 5′ NCR serve as an internal
ribosome entry site (IRES) for translation initiation (Jang et al., 1988;
Pelletier and Sonenberg, 1988). The exact mechanism of IRES-
mediated translation initiation has not been elucidated; however, it
has been postulated that the interaction of trans-acting host factors
46 P. Sean et al. / Virology 389 (2009) 45–58with cis-acting stem-loop structures and helices acts to recruit
canonical and non-canonical translation factors and/or stabilize the
RNA for translation. The IRES elements of picornaviruses are divided
into three types based on sequence and structural homology. Viruses
containing type I IRES elements include poliovirus, coxsackievirus,
and rhinovirus; those of type II include foot and mouth disease virus
(FMDV) and encephalomyocarditis (EMCV). Hepatitis A virus (HAV)
has a type III IRES (Wimmer et al., 1993; Jackson and Kaminski, 1995;
Borman et al., 1997).
The RNA secondary structures of poliovirus and coxsackievirus 5′
NCRs have been solved through both enzymatic and chemical
structure probing (Skinner et al., 1989; Bailey and Tapprich, 2007;
Stewart and Semler, 1998). Overall, the RNA secondary structures that
form in the 5′ NCR of these two enteroviruses are well conserved.
The secondary structures of the 5′ NCR of enteroviruses have two
distinct functions: cap-independent translation and RNA replication
(Ehrenfeld and Teterina, 2002). At the very 5′ end of the RNA is a
highly conserved cloverleaf-like secondary structure termed stem-
loop I. Enterovirus stem-loop I has been shown to be important for
negative-strand RNA synthesis (Andino et al., 1990; Parsley et al.,
1997; Bell et al., 1999). Stem-loops II through VI make up the IRES and
are required for cap-independent translation (Pelletier and Sonen-
berg, 1988; Trono et al., 1988; Murray et al., 2004). Poliovirus stem-
loop IV, a large 205 nucleotide-long cruciform-like structure in the
middle of the IRES, has been identiﬁed as a major cis-acting element
for translation initiation (Blyn et al., 1995). Poliovirus stem-loop IV
presents two poly(C) loops and a GNRA tetra-loop, identiﬁed as a very
stable motif, at the apex (Antao et al., 1991). A single nucleotide
mutation at position 325 of stem-loop IV reduced translation of
poliovirus in HeLa cell extract (Blyn et al., 1995). Nucleotide substitu-
tions in the poly(C) region at position 332 completely abolished
poliovirus IRES-mediated translation (Gamarnik and Andino, 2000).
To date, the only cellular protein identiﬁed to have a deﬁnitive role
in both enterovirus RNA replication and IRES-mediated translation is
the cellular poly(rC) binding protein (PCBP) (Parsley et al., 1997;
Gamarnik and Andino, 1997; Walter et al., 2002). PCBPs are RNA
binding proteins that preferentially bind to single-stranded stretches
of cytidines (for review see, Makeyev and Liebhaber, 2002). There are
four isoforms of PCBPs, each having three K-homology (KH) domains,
which are consensus RNA binding domains that fold according to a
β1α1α2β2β3α3 motif (Siomi et al., 1993; Dejgaard and Leffers, 1996).
In the cell, PCBPs function by interacting with poly(C) stretches in the
3′ NCR of speciﬁc cellular mRNAs and stabilizing these messenger
RNAs, as in the case ofα-globin, or bymodulating translation, as in the
case of lipoxygenase (Weiss and Liebhaber, 1994; Ostareck et al.,
1997). Co-crystal structures of the KH1 domain of PCBP2 with human
telomeric DNA shows that the poly(C) nucleotides interact with a
groove that is generated between α1α2 and β2β3 (Du et al., 2005).
Similar to cellular mRNAs, it has also been shown that the interaction
of PCBPs with poliovirus stem-loop I contributes to the overall
stability of the viral RNA in vitro (Murray et al., 2001).
In addition to forming ribonucleoprotein (RNP) complexes with
RNA, PCBPs can also participate in protein–protein interactions. In
yeast-two hybrid screens, it was shown that PCBP1, PCBP2, and hnRNP
K can homo- and hetero-dimerize in various combinations (Kim et al.,
2000; Bedard et al., 2004). PCBP2 has also been shown to interact with
multiple RNA-binding proteins, including poly(A) binding protein
(PABP) and two proteins involved in splicing, SRp20 and 9G8 (Funke
et al., 1996; Wang et al., 1999; Bedard et al., 2007).
Of the four PCBP isoforms, only PCBP1 and PCBP2 have been
experimentally shown to have roles in the replication cycles of
enteroviruses (i.e., poliovirus and coxsackievirus). The interaction of
PCBP1/2 and the viral polymerase precursor 3CD with poliovirus
stem-loop I RNA forms a ternary complex, a required step in negative-
strand RNA synthesis (Andino et al., 1990; Parsley et al., 1997;
Gamarnik and Andino, 1997; Perera et al., 2007). Ternary complexformation might facilitate circularization of the viral RNA template,
through an interactionwith PABP on the 3′ poly(A) tract, for negative-
strand RNA synthesis (Barton et al., 2001; Herold and Andino, 2001).
In HeLa cell cytoplasmic extracts depleted of PCBPs, poliovirus RNA
replication was inhibited; however, addition of recombinant PCBPs
rescued RNA replication to near mock-depleted levels (Walter et al.,
2002).
Beyond its role in viral RNA replication, PCBP2 is an IRES trans-
acting factor (ITAF). In HeLa cell cytoplasmic extracts depleted of
PCBPs, poliovirus IRES-mediated translation is greatly reduced (Blyn
et al., 1997). This translation defect can be rescued by addition of
recombinant PCBP2, but not PCBP1 (Blyn et al., 1997). The ability of
PCBP2 to rescue poliovirus IRES-mediated translation results from its
ability to bind poliovirus stem-loop IV RNA, whereas PCBP1 cannot
(Walter et al., 2002; Sean et al., 2008). PCBP2 interaction with
poliovirus stem-loop IV requires a stretch of single-stranded poly(C)
residues (Blyn et al., 1996; Gamarnik and Andino, 2000). Speciﬁc
nucleotide insertions and substitutions in poliovirus stem-loop IV RNA
that inhibit PCBP2 binding also inhibit poliovirus IRES-mediated
translation (Blyn et al., 1996; Gamarnik and Andino, 2000). In fact,
PCBP2 has been shown to be required for cap-independent translation
initiation of several type I IRES-containing picornaviruses (Blyn et al.,
1997; Walter et al., 1999). The exact mechanism by which PCBP2
mediates translation has not been elucidated, but it is possible that the
interaction of PCBP2 with poliovirus stem-loop IV RNA recruits
ribosomes via protein–protein interactions or by stabilizing the RNA
structure for internal ribosome entry (Bedard et al., 2007).
Genetic evidence suggests that a conserved mechanism of virus–
host interaction is required for the intracellular replication cycles of
poliovirus and coxsackievirus. Semler and colleagues showed that a
chimeric poliovirus containing the 5′ NCR of coxsackievirus displayed
a near wild type growth phenotype (Johnson and Semler, 1988) even
though at the nucleotide level, the 5′ NCRs of these two viruses share
only ∼70% identity (Semler et al., 1986). We reasoned that the
coxsackievirus IRES, like that of poliovirus, contains RNA secondary
structures which form RNP complexes with host cell proteins to
mediate cap-independent translation initiation. In this report, we
describe enzymatic RNA structure probing and RNase foot-printing
experiments to identify the CVB3 stem-loop IV sequences required for
interaction with PCBP2. Our data conﬁrm previous structure probing
studies (Gamarnik and Andino, 2000; Bailey and Tapprich, 2007),
showing that coxsackievirus stem-loop IV RNA folds into a secondary
structure similar to that of poliovirus stem-loop IV RNA, including a
GNRA tetra-loop at the apex, a poly(C) loop at a 5′ proximal hairpin,
and a single-stranded polypyrimidine (Py)-bulge that is adjacent to
the GNRA tetra-loop. Using mobility shift assays, we show that
coxsackievirus stem-loop IV RNA interacts with PCBP2 at a reduced
binding afﬁnity compared to poliovirus stem-loop IV. Foot-printing
experiments revealed three major regions of stem-loop IV RNA that
are protected by PCBP2 from RNase digestion, two of which included
or were proximal to the poly(C)-loop and (Py)-bulge sequences.
When the poly(C) sequences and (Py)-bulge sequences in coxsack-
ievirus stem-loop IV were separately mutated to guanosines, the
interaction of the RNAswith PCBP2was greatly reduced [especially for
the (Py)-bulge substitution to poly(G)]. Using in vitro translation
assays of luciferase reporter constructs, we found that substitution of
poly(G) for either the poly(C)-loop or the (Py)-bulge in coxsackievirus
stem-loop IV produced four- or ten-fold reductions, respectively, in
IRES-mediated translation. Surprisingly, when these same poly(G)
nucleotide substitutions were engineered into full-length CVB3 RNA
transcripts, both constructs produced infectious virus. However, the
speciﬁc infectivities of the mutated RNAs were reduced and the
recovered viruses displayed smaller plaque sizes and slower replica-
tion kinetics compared towild type CVB3.We discuss the implications
of these ﬁndings in the context of additional host factors that may play
a role in coxsackievirus translation initiation.
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Enzymatic structure probing and m-fold prediction of coxsackievirus
stem-loop IV RNA
To determine if the coxsackievirus 5′ NCR contains an RNA
secondary structure that folds and functions like poliovirus stem-
loop IV RNA, we employed both enzymatic structure probing
experiments and computer-based RNA structure modeling. A coxsack-
ievirus stem-loop IV RNA was generated by sub-cloning sequences
corresponding to poliovirus stem-loop IV from the 5′ NCR of a full-
length coxsackievirus genomic cDNA (Chapman et al., 1994). In vitro
transcribed 32P end-labeled coxsackievirus stem-loop IV RNAs were
subjected to partial digestion by single-strand, base-speciﬁc RNases (A
and T1) and a double-strand speciﬁc RNase, V1. The reactions were
then resolved on sequencing gels in parallel with untreated coxsack-
ievirus stem-loop IV RNA. An example of the results of one of several
structure probing experiments carried out on CVB3 stem-loop IV RNA
is shown in Fig. 1A. The nucleotides identiﬁed from enzymatic
structure probing were then used as constraints for m-fold (Mathews
et al., 1999; Zuker, 2003), a computer algorithm that predicts
secondary structure based on the thermodynamics of base pair
interactions. The resulting output reveals a cruciform-like RNA
secondary structure (Fig. 1B). Nucleotides in bold were identiﬁed by
our enzymatic structure experiments. Overall, the secondary structure
of coxsackievirus stem-loop IV RNA bears a strong similarity to
poliovirus stem-loop IV RNA, having a GNRA tetra-loop at the apex, a
poly(C)-loop at the 5′ proximal hairpin, and a polypyrimidine-bulge
[poly(Py)-bulge] that is adjacent to the GNRA tetra-loop. Slight
differences between the two stem-loop structures were also observed.
Coxsackievirus stem-loop IV RNA has an internal bulge that is 18
nucleotides in length, and the poly(C) stem is shorter than poliovirus
stem-loop IV by 7 paired nucleotides. Our structure of coxsackievirus
stem-loop IV conﬁrms, for the most part, a previously-published
secondary structure that was determined by chemical probing
methods (Bailey and Tapprich, 2007). However, there are predicted
differences in the sizes of several internal bulge sequences as well as in
the length of base-paired stem regions.
Coxsackievirus stem-loop IV RNA binds to PCBP2
The secondary structure of coxsackievirus stem-loop IV presents
two single-stranded polypyrimidine motifs (refer to Fig. 1A), which
are potential PCBP binding sites (Leffers et al., 1995; Blyn et al., 1996;
Parsley et al., 1997). Previously, it was shown that PCBP2 can interact
with two sites on coxsackievirus stem-loop I RNA, at the b-loop and at
the poly(C) region directly downstream (Bell et al., 1999; Zell et al.,
2008). Also, the complete 5′ NCR of coxsackievirus RNA can compete
with poliovirus stem-loop IV for PCBP2 binding inmobility shift assays
(Walter et al., 1999). To determine if coxsackievirus stem-loop IV RNA
interacts directly with PCBP2, we performed electrophoretic mobility
shift assays with recombinant PCBP2. At low concentrations of PCBP2
(50–100 nM), distinct RNP complexes are readily detected with 32P-
labeled poliovirus stem-loop IV RNA (Fig. 2A, lanes 2–3). The apparent
afﬁnity of PCBP2 appears to beweaker for coxsackievirus stem-loop IV
RNA, as evidenced by probe smearing and the lack of discrete RNP
complex formation (Fig. 2A, lanes 5–6). At higher concentrations of
PCBP2 (250–750 nM), a discrete RNP complex forms in a dose-
dependent manner, along with a concomitant disappearance of free
probe (Fig. 2A, lanes 8–10).
Mobility shift assays of coxsackievirus stem-loop IV RNA and
PCBP1, an isoform that does not interact with poliovirus stem-loop
IV RNA, were also performed (Walter et al., 2002). In agreement
with data reported for poliovirus, coxsackievirus stem-loop IV does
not interact with PCBP1 (Fig. 2A, lanes 12–13). The selective
interaction of coxsackievirus stem-loop IV with PCBP2 and notPCBP1 suggests the conservation of protein utilization in IRES-
mediated translation between both poliovirus and coxsackievirus
(Sean et al., 2008).
The mobility shift assays indicate that the apparent afﬁnity of
PCBP2 for coxsackievirus stem-loop IV RNA is lower compared to
poliovirus stem-loop IV. To determine the relative afﬁnity of PCBP2 for
coxsackievirus stem-loop IV RNA, we performed competition electro-
phoretic mobility shift assays of radiolabeled poliovirus stem-loop IV
RNA and PCBP2 (Fig. 2B). RNP complexes were formedwith poliovirus
stem-loop IV RNA and 50 nM PCBP2 (Fig. 2B, lane 2). Increasing molar
excesses of either unlabeled poliovirus or coxsackievirus stem-loop IV
RNAs were then added to compete for binding to PCBP2. At 10–25 nM
unlabeled poliovirus stem-loop IV RNA, half of the radiolabeled
poliovirus stem-loop IV/PCBP2 RNP complex disappears (Fig. 2B,
lanes 3–4); however, 50 nM unlabeled coxsackievirus stem-loop IV
RNA is required to compete for PCBP2 binding (Fig. 2B, lanes 8–9). We
calculated the percentage of radiolabeled poliovirus stem-loop IV RNA
bound against molar excess of unlabeled competitor RNA and
determined that the apparent KD of PCBP2 for poliovirus stem-loop
IV is ∼15 nM (Fig. 2C), which is in agreement with previously
published data (Gamarnik and Andino, 2000). The apparent KD of
PCBP2 for coxsackievirus stem-loop IV RNA is ∼35 nM. The lowered
afﬁnity of PCBP2 for coxsackievirus stem-loop IV RNA (compared to
poliovirus stem-loop IV) might be due to differences in structural
features, which include a shorter stem presenting the poly(C)-loop
and only two predicted single-stranded cytidines in the poly(Py)-
bulge, compared to three single-stranded cytidines on poliovirus
stem-loop IV (Fig. 1B).
RNase foot-printing analysis of coxsackievirus stem-loop IV RNA and
PCBP2
After determining that the apparent afﬁnity of PCBP2 for
coxsackievirus stem-loop IV is lower when compared to poliovirus
stem-loop IV, we performed RNase foot-printing analysis to more
carefully examine this interaction. The higher afﬁnity observed for
PCBP2 and poliovirus stem-loop IV (compared to coxsackievirus stem-
loop IV) may be the result of PCBP2 interactions with three regions of
the RNA that were protected from RNase T1 and T2 digestion
(Gamarnik and Andino, 2000). Foot-printing data showed that
PCBP2 interacted with two single-stranded loops and a bulge
sequence in poliovirus stem-loop IV RNA (Gamarnik and Andino,
2000). We performed RNase foot-printing assays with 5 μM PCBP2
using the same experimental conditions employed in our enzymatic
structure probing experiments (Fig. 3A). PCBP2 protected three major
regions of coxsackievirus stem-loop IV RNA from RNase A and V1
digestion, denoted by A, B, and C (Fig. 3B). The foot-printing assay
shows that three cytidines which form the poly(C)-loop and adjacent
stem were protected. A double-stranded region along the helix of
coxsackievirus stem-loop IV RNAwas also protected by PCBP2, as well
as three helical regions adjacent to the poly(Py)-bulge. The RNase
foot-printing assay showed that PCBP2 protects three major regions
within coxsackievirus stem-loop IV RNA from nuclease digestion. The
RNase protection observed on the stem structure may result from the
variable nucleotide sequence motifs that interact with PCBP2.
Although there is a preference for binding poly(rC) motifs, it has
been shown that the KH domains of PCBPs can interact with
homopolymers of poly(rU), poly(rG), double-stranded RNA, or DNA
(Leffers et al., 1995; Dejgaard and Leffers, 1996). Given that our RNase
foot-printing experiments identiﬁed three regions on the RNA that are
protected by PCBP2 and that each protein has three KH domains
(RNA-binding domains), it is possible that one molecule of RNA
interacts with one molecule of PCBP2; however, the exact stoichio-
metry of the interaction cannot be determined accurately due to the
fact that a molar excess of protein was used, and due to the homo-
dimerization capability of PCBP2.
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binding
Our RNase foot-printing experiments identiﬁed sequences in
coxsackievirus stem-loop IV RNA that are protected from nuclease
digestion; however, protection does not necessarily demonstrate
direct interaction with the protein. The secondary structure of
coxsackievirus stem-loop IV presents two single-stranded polypyr-Fig. 1. Secondary structure determination of coxsackievirus stem-loop IV RNA. (A) Enzyma
stem-loop IV RNA (20–40 ng) was digested with RNase A (lanes 3–6), T1 (lanes 7–14) and
digested for 1–3 min at 25 °C with RNase dilutions of 1:1 and 1:10 from stock. Urea (1 mM)
strand speciﬁc RNases used were RNase A, which cleaves after C and U residues, and RNase T
Undigested, full-length end-labeled coxsackievirus stem-loop IV RNAs are seen at the top of
cleavage products are from completely formed RNA structures. The bands in the RNase-dige
designates the partial alkaline hydrolysis ladder for coxsackievirus stem-loop IV RNA. (B) M
bold were identiﬁed through RNase structure probing. The structure shown represents nuc
tetra-loop are indicated by dashed-line boxes.imidine tracts, whichmay provide binding sites for PCBP2 (Fig. 1B). To
examine the importance of the single-stranded polypyrimidine
residues of coxsackievirus stem-loop IV RNA, the poly(C)-loop and
the poly(Py)-bulge were separately mutated to poly(G) sequences
(Fig. 4A). Mutated stem-loop IV RNAs were then assayed for binding
to PCBP2 and, subsequently, for the ability to mediate IRES-dependent
translation. The poly(G)-loop was constructed by mutating the four
cytidines in the loop to four guanosines. The poly(G)-bulge wastic structure probing of coxsackievirus stem-loop IV RNA. Radio-labeled coxsackievirus
V1 (lanes 15–18), and the T1 ladders are shown in lanes 9, 10, 13, and 14. The RNA was
was added to the T1 digestion to obtain a G-ladder (lanes 8–9 and 12–13). The single-
1, which cleaves after G residues. RNase V1 was used to identify base-paired nucleotides.
the gel. This shows “one-hit kinetics” of RNase digestion and ensures that the observed
sted lanes correspond to speciﬁc nucleotides cleaved by the RNases. L (lanes 1 and 19)
-fold predicted secondary structure of coxsackievirus stem-loop IV RNA. Nucleotides in
leotides 235 to 430 for coxsackievirus B3. The poly(C)-loop, poly(Py)-bulge, and GNRA
Fig. 1 (continued).
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Fig. 2. Mobility shift assays of coxsackievirus stem-loop IV RNAwith PCBP2 and PCBP1. (A) Electrophoretic mobility shift assays of poliovirus and coxsackievirus stem-loop IV RNAwith
recombinant PCBP2 and PCBP1. In vitro transcribed, 32P-labeled stem-loop IV RNA at a ﬁnal concentration of 0.1 nMwas incubatedwith increasing amounts of puriﬁed recombinant PCBP2
for 10 min at 30 °C, and the reactionwas then subjected to native polyacrylamide gel electrophoresis. Lanes 1, 4, 7, and 11 are the RNA alone. Poliovirus stem-loop IV RNA (lanes 2–3) and
coxsackievirus stem-loop IVRNA (lanes 5–6 and 8–10) can form ribonucleoprotein (RNP) complexeswith PCBP2. The RNP complex is denoted by the arrow. PCBP1 (lanes 12–13) is unable
to interactwith coxsackievirus stem-loop IVRNA. (B) Competition electrophoreticmobility shift assay of poliovirus stem-loop IV RNA and PCBP2 using unlabeled coxsackievirus stem-loop
IV RNA. In vitro transcribed 32P-labeled poliovirus stem-loop IV RNA (1 nM) was incubated with PCBP2 (50 nM) in the presence of increasing amounts of unlabeled poliovirus (lanes 3–6)
or coxsackievirus stem-loop IV RNAs (lanes 7–10) for 10min at 30 °C. The RNP complexes were then resolved on a native polyacrylamide gel. RNP complexes are denoted by the arrow. (C)
Graph of relative binding afﬁnities of PCBP2 for poliovirus and coxsackievirus stem-loop IV RNA. The relative afﬁnities of PCBP2 for the stem-loop IV RNAswere determined by measuring
the band intensity of the bound RNAdivided by the sumof the free RNA and boundRNA. Itwas observed that 15 nMunlabeled poliovirus stem-loop IVRNAwas enough to dissociate half of
the labeled poliovirus stem-loop IV–PCBP2 RNP complex, while it required 35 nM unlabeled coxsackievirus stem-loop IV RNA to obtain the same level of competition.
50 P. Sean et al. / Virology 389 (2009) 45–58constructed by mutating the three cytidines in the bulge and one
adjacent cytidine in the helical domain to guanosines.
The results of mobility shift assays of PCBP2 with the poly(G)-
substituted coxsackievirus stem-loop IV RNAs are displayed in Fig. 4B.
When increasing amounts of PCBP2 were added to wild type
coxsackievirus stem-loop IV RNA, there was a concomitant dose-
dependent increase in RNP complex formation and disappearance of
free probe, indicating a stable interaction (Fig. 4B, lanes 2–4). As noted
above, we used high concentrations of PCBP2 (250–750 nM) because
50 to 100 nM PCBP2 did not result in the formation of discrete RNP
complexes (Fig. 2A). When the same concentrations of PCBP2 were
incubated with the poly(G)-bulge coxsackievirus stem-loop IV RNA,
no RNP complexes could be detected, even at the highest concentra-
tion (Fig. 4B, lanes 7–9). When increasing amounts of PCBP2 were
added to the poly(G)-loop coxsackievirus stem-loop IV RNA, a dose-
dependent RNA-protein interaction was observed. The apparent
afﬁnity is lower than that of wild type stem-loop IV, since the signalfor the RNP complex was not as intense (compare Fig. 4B, lanes 2 and
12) and there was no complete disappearance of free probe as
observed for the wild type RNA (Fig. 4B, lanes 12–14). The mobility
shift assay shows that the poly(G) nucleotide substitutions in
coxsackievirus stem-loop IV RNA reduced binding of PCBP2 to
different extents. The poly(G)-loop reduced PCBP2 binding only
slightly, whereas the poly(G)-bulge mutations completely abrogated
binding to PCBP2, even though the poly(C)-loop is still intact in this
second mutated construct. It is possible that the poly(G) nucleotide
substitutions generated near the GNRA tetra-loop (refer to Fig. 4A)
cause destabilization of the RNA.
Poly(G) substitutions in coxsackievirus stem-loop IV RNA cause impaired
translation in vitro
The mobility shift assays indicated that the poly(C) sequences in
coxsackievirus stem-loop IV RNA are important for binding to PCBP2.
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translationwas abrogated when poliovirus stem-loop IV RNA failed to
interact with PCBP2 (Blyn et al., 1996; Gamarnik and Andino, 2000).
To examine the effects of the poly(G) substitutions on coxsackievirus
IRES-mediated translation, we carried out in vitro translation assays
using a reporter RNA in HeLa cell cytoplasmic extracts. We engineered
the poly(G) nucleotide substitutions into a coxsackievirus 5′ NCR-
luciferase reporter RNA inwhich translation of the luciferase protein is
driven by the coxsackievirus IRES. Both poliovirus and wild type
coxsackievirus 5′ NCR-luciferase reporter RNAs were efﬁciently
translated in HeLa cell cytoplasmic extract (Fig. 5). Translation of
the reporter RNAs containing the poly(G) nucleotide substitutions
was greatly reduced compared to wild type, at ∼10% and ∼23% for the
poly(G)-bulge and poly(G)-loop, respectively. The in vitro translation
data show that the poly(G)-bulge nucleotide substitutions have a
more pronounced inhibition of coxsackievirus IRES-mediated transla-
tion than the poly(G)-loop substitutions, a trend that is consistent
with our mobility shift assay data. Although the mobility shift assays
showed a nearly complete lack of PCBP2 binding for the poly(G)-bulge
stem-loop IV RNA, these substitutions still mediated translation at
levels 10% of wild type RNA, suggesting that a lack of PCBP2
interaction at this site does not completely abrogate IRES-mediated
translation initiation.
Effects of stem-loop IV poly(G) substitutions on coxsackievirus infectivity
and growth properties
As a functional complement to our in vitro analyses of PCBP2
interaction with coxsackievirus stem-loop IV RNAs, we used RNA
transfections of HeLa cells to determine if full-length viral RNAs
containing either of the two poly(G) substitutions in stem-loop IV
were infectious. Wild type and mutated RNAs were transcribed in
vitro, serially diluted, and then transfected into HeLa cell monolayers.
Both mutated RNAs were capable of producing virus, and plaques
were visible by 3 days post-transfection (Fig. 6A). Coxsackievirus
RNAs containing the poly(G)-loop mutated stem-loop IV formed
plaques with a speciﬁc infectivity approximately one-half of that
observed for wild type RNAs (data not shown). In addition, the plaque
sizes for this mutant were slightly smaller than those of wild type
(refer to Fig. 6A). The poly(G)-bulge substituted stem-loop IV mutant
formed plaques at a speciﬁc infectivity of less than one-tenth of that of
wild type RNA (data not shown), and the plaque sizes were much
smaller than those of wild type (Fig. 6A). Virus stocks generated from
plaque isolates of these mutants (and wild type CVB3) were used to
infect HeLa cells in single cycle growth experiments. As shown in Fig.
6B, the growth of both mutant viruses was delayed markedly
compared to wild type virus, with titers reduced by more than one
log10 unit at 4 h post-infection for the poly(G)-loop mutant and by
nearly two log10 units for the poly(G)-bulge mutant. By 8 h post-
infection, both of the mutants had reached titers that were within one
log10 unit of wild type coxsackievirus, suggesting that synthesis of
viral proteins eventually achieved sufﬁcient levels to produce near
wild type titers of virus. Genomic RNAs recovered following infections
of HeLa cells with these mutant viruses showed that the stem-loop IV
targeted mutations were intact, and no additional nucleotide changes
were detected in the 5′ NCRs of the mutant viruses (data not shown).
The smaller plaque sizes and reduced virus growth kinetics observed
for coxsackievirus RNAs containing the different poly(G) mutated
stem-loop IV sequences correlated with the lower in vitro IRES-
mediated translation efﬁciency and reduced PCBP2 binding that these
mutations conferred.
Discussion
Immediately after uncoating in the cytoplasm, secondary struc-
tures that form in the 5′ NCR of coxsackievirus RNA recruit bothcanonical and non-canonical translation factors to mediate cap-
independent translation. By hijacking cellular components for their
own gene expression, picornaviruses exploit an alternative mechan-
ism of internal initiation of translation that already exists in the cell.
The interaction of IRES trans-acting factors (ITAFs) with RNA
secondary structures has been shown to stimulate picornavirus
IRES-mediated translation. Several RNA-binding proteins have been
identiﬁed as ITAFs, including PCBP2, the La autoantigen, unr
(upstream of N-Ras), and polypyrimidine tract binding protein
(PTB) (Blyn et al., 1996; Meerovitch et al., 1993; Hunt et al., 1999;
Jang and Wimmer, 1990; Hellen et al., 1993; Borman et al., 1993). The
interaction of ITAFs with IRES elements may provide a functional
equivalent to eIF4F binding to a 5′ cap structure, which picornaviruses
lack, as well as an RNA chaperone-like function to stabilize IRES
structures (Song et al., 2005).
Using dicistronic constructs in rabbit reticulocyte lysates supple-
mented with HeLa cell extract, Yang et al. (1997) determined that the
5′ NCR of coxsackievirus contains an internal ribosomal entry site for
translation. In a subsequent study, the same group used coxsack-
ievirus 5′ NCR deletion mutations to map the IRES to nucleotides
∼430–640, encompassing several predicted stem-loop structures (Liu
et al., 1999). Based on thework of Semler and colleagues, we predicted
that the secondary structures of enterovirus 5′ NCRs are conserved in
both form and function (Semler et al., 1986; Johnson and Semler,
1988). For poliovirus, the IRES sequence was reported to be between
nucleotides ∼130 and 600, encompassing all or part of stem-loops II–
VI (Pelletier and Sonenberg,1988; Skinner et al., 1989; Nicholson et al.,
1991), indicating that the 5′ border is ∼300 nucleotides upstream of
that previously reported for CVB3. Stem-loop IV of CVB3 RNA has been
shown to be contained within nucleotides ∼240–445 (Bailey and
Tapprich, 2007), suggesting that the coxsackievirus IRES encompasses
sequences beyond those originally reported (Liu et al., 1999). In
this report, we presented evidence that CVB3 stem-loop IV is a major
cis-acting element important for coxsackievirus IRES-mediated
translation.
Enzymatic structure probingwith strand-speciﬁc RNases andm-fold
computer modeling indicated that sequences in the coxsackievirus 5′
NCR, corresponding to poliovirus stem-loop IV, form a secondary
structure similar to poliovirus stem-loop IV. Overall, the structure of
coxsackievirus stem-loop IV forms a cruciformwith three hairpin loops
and a GNRA tetra-loop at the apex. Like poliovirus, coxsackievirus stem-
loop IVRNA interactswith PCBP2, albeitwith a lower afﬁnity. Our RNase
foot-printing data showed that PCBP2 protects three major regions of
coxsackievirus stem-loop IV RNA from RNase digestion: the poly(C)-
loop, the stem adjacent to the large internal bulge, and the region
adjacent to the poly(Py)-bulge. Although there was not a clear PCBP2
protection due to multiple pyrimidine nucleotides that form the poly
(Py)-bulge, we predict that the bulge motif is interacting with PCBP2
and thus protecting the adjacent regions from RNase digestion. The
sequences of coxsackievirus stem-loop IV RNA that were protected by
PCBP2 from RNase digestionwere in the same general domains as those
previously identiﬁed for poliovirus stem-loop IV (Gamarnik andAndino,
2000). Although our RNase foot-printing data showed that multiple
regions of the RNA are protected, several features of the PCBP2/stem-
loop IV interaction make it difﬁcult to determine the speciﬁc RNA:
protein stoichiometry, including multiple RNA binding domains on the
protein and multiple PCBP2 binding sites on the RNA. In mobility shift
assays, when increasing amounts of PCBP2 (250–750 nM) were
incubated with coxsackievirus stem-loop IV RNA, three complexes
formed with slightly different electrophoretic mobilities (refer to Fig.
2A). We suspect that the formation of the slower migrating complex
results from PCBP2 dimerization, rather than saturating RNA-protein
contacts because at 250nMPCBP2 therewas anexcess ratio of protein to
RNA (2500:1). Ultimately, co-crystallization of stem-loop IV RNA and
PCBP2 will be required to further illuminate the nature of this
interaction.
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coxsackievirus stem-loop IV RNA, the interaction with PCBP2 was
somewhat reduced; however, when the poly(Py)-bulge was mutated
to poly(G), the interaction was almost completely abolished. The
ﬁnding that the poly(G)-bulge dramatically inhibited interaction
with PCBP2 is in agreement with previous studies on poliovirus
stem-loop IV. A nucleotide mutation at position 325 or a ﬁve
nucleotide substitution starting at position 332 in poliovirus stem-
loop IV RNA inhibited both interaction with PCBP2 and IRES-
mediated translation (Blyn et al., 1996; Gamarnik and Andino,
2000). NMR structure studies of the poly(C)-bulge of poliovirus
stem-loop IV RNA show that when the cytidine at position 334 is
changed to a uridine, the bulge becomes less ﬂexible (when
compared to wild type stem-loop IV) and adopts a U-shape instead
of an L-shape (Du et al., 2004). We speculate that generatingFig. 3. RNase foot-printing assay of coxsackievirus stem-loop IV RNA and PCBP2. (A) PCB
coxsackievirus stem-loop IV RNA (20–40 ng) was incubatedwith 5 μMof PCBP2, denoted by+
14–17) digestion. The RNAs were digested for 1–3 min at 25 °C with RNase dilution of 1:1 and
10 and 13). Boxes indicate nucleotides within coxsackievirus stem-loop IV RNA that were pro
hydrolysis ladder for coxsackievirus stem-loop IV RNA. (B) Secondary structure showing re
digestion (denoted by boxes). PCBP2 protects the poly(C)-loop, the stem leading to the intemutations in a region directly adjacent to the GNRA tetra-loop
disrupts the overall RNA secondary structure, and not just the
structure of the targeted motif.
When the two poly(G) nucleotide mutations were individually
engineered into a coxsackievirus 5′NCR-luciferase reporter RNA, IRES-
mediated translation was greatly reduced, supporting previous
evidence for poliovirus that interaction of stem-loop IV with PCBP2
stimulates IRES-mediated translation. Poliovirus stem-loop IV RNA
contains two poly(C) sequences that interact with PCBP2 (Gamarnik
and Andino, 2000). Similar to its poliovirus counterpart, coxsack-
ievirus stem-loop IV RNA also presents two single-stranded sequences
that may interact with PCBP2. The utilization of PCBPs to mediate
important functions in the enterovirus life cycle results from the
multi-functional properties of these proteins during interactions with
both nucleic acids and proteins.P2 protection of multiple regions of coxsackievirus stem-loop IV RNA. Radio-labeled
, at 30 °C for 10min and subjected to RNase A (lanes 4–7), T1 (lanes 8–13) and V1 (lanes
1:10 from stock. Urea (1 mM) was added to the T1 digestion to obtain a G-ladder (lanes
tected by PCBP2 from RNase cleavage. L (lanes 1 and 18) designates the partial alkaline
gions of sequence in coxsackievirus stem-loop IV RNA protected by PCBP2 from RNase
rnal bulge, and the helix region adjacent to the poly(Py)-bulge.
Fig. 3 (continued).
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Fig. 4. Mobility shift assay of poly(G) substituted coxsackievirus stem-loop IV RNA with PCBP2. (A) M-fold predicted secondary structure of wild type, poly(G)-loop and poly(G)-
bulge substituted coxsackievirus stem-loop IV RNAs.Wild type sequences corresponding to the poly(C)-loop or poly(C)-bulge are boxedwith solid lines while mutated sequences are
boxed with dashed lines. (B) In vitro transcribed 32P-labeled wild type (lanes 1–5), poly(G)-bulge (lanes 6–10), and poly(G)-loop (lanes 11–15) coxsackievirus stem-loop IV RNAs
(1 nM) were incubated with increasing amounts of puriﬁed recombinant PCBP2 (250–750 nM) for 10 min at 30 °C. The reactions were then resolved by native polyacrylamide gel
electrophoresis. Lanes 1, 6, and 11 are the RNA alone. RNP complexes and free probe RNAs are denoted by arrows. Competition mobility shift assays were carried out with 100 nM
unlabeled poliovirus stem-loop IV RNA (lanes 5, 10, and 15).
54 P. Sean et al. / Virology 389 (2009) 45–58Previous studies have shown that sequence integrity of the
picornavirus IRES is required for successful infection. Alterations to
nucleotide sequence or secondary structure may have detrimental
effects on protein binding and thus adversely affect translation and
pathogenesis. A single point mutation in domain V of the poliovirus
IRES was shown to attenuate the virus for poliomyelitis (Evans et al.,
1985; Kawamura et al., 1989). It was shown that growth of the Sabin
strain (which harbors this mutation) was restricted in neuronal cell
lines (Agol et al., 1989; La Monica and Racaniello, 1989). For
coxsackievirus, stem-loop II of the 5′ NCR is a major determinant for
cardiovirulence (Dunn et al., 2003). In addition, a point mutation atposition 234 of the 5′ NCR attenuates the virus for cardiovirulence,
even though the virus harboring this mutation replicated to the same
level as the cardiovirulent strain in cardiomyocytes (Tu et al., 1995). By
exchanging the cardiovirulence domain of coxsackievirus (located in
the 5′ NCR) with the corresponding region of poliovirus RNA,
Chapman et al. (2000) showed that the chimeric virus displayed
replication defects in tissue culture. When mice were inoculated with
this chimeric virus, it provided protection against heart and pancreatic
lesions when challenged with a pathogenic strain.
We demonstrated that when the poly(C) motifs of coxsackievirus
stem-loop IV were mutated to poly(G) in full-length cDNAs, the
Fig. 5. Luciferase assay of coxsackievirus IRES with poly(G) substitutions in stem-loop IV. A. Luciferase reporter RNAs (50 fmol) containing the poliovirus 5′ NCR, coxsackievirus 5′
NCR, poly(G)-loop coxsackievirus 5′ NCR, or poly(G)-bulge coxsackievirus 5′ NCR were incubated in HeLa S10 cytoplasmic extracts for 2.5 h at 30 °C and then assayed for luciferase.
The relative light unit (RLU) values are the averages from three separate experiments.
55P. Sean et al. / Virology 389 (2009) 45–58speciﬁc infectivities of the resulting RNA transcripts were reduced.
The recovered mutant viruses had small-plaque phenotypes and
signiﬁcantly slower growth kinetics compared to wild type CVB3.Fig. 6. Growth properties of coxsackievirus mutants with poly(G) substitutions in stem-loop
loop, or poly(G)-bulge mutated stem-loop IV coxsackievirus RNAs were transfected into HeL
coxsackievirus RNA produced large plaques, while the poly(G) mutated stem-loop coxsackie
mutants with poly(G) nucleotide substitutions in stem-loop IV. HeLa cell monolayers were in
coxsackieviruses at a multiplicity of infection (MOI) of 10. The infected monolayers were h
plaque assay on HeLa cells as described in Materials and methods. The virus titers are repoGiven the almost complete lack of binding of PCBP2 to mutated stem-
loop IV RNA and the ∼10-fold reduction in translation activity, the
recovery of infectious virus harboring the poly(G)-bulge substitutionIV RNA. A. Plaque size morphology. In vitro transcribed full-length wild type, poly(G)-
a cell monolayers. Readily visible plaques formed at 3 days post-transfection. Wild type
virus RNAs produced smaller plaques. B. Single cycle growth analysis of coxsackievirus
fectedwith wild type−♦−, poly(G)-loop , or poly(G)-bulge mutated
arvested at the indicated times after infection and the virus titers were determined by
rted as the log10 PFU (plaque forming units) per milliliter (ml).
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present in recovered virus and no additional mutations were found in
the 5′NCR, we assume that other canonical or non-canonical factors in
the cytoplasm of HeLa cells are able to substitute for a putative
chaperone-like function of PCBP2 required for CVB3 translation,
although at a much-reduced level of biological efﬁciency. Such factors
may contribute to the cardiac- and pancreas-speciﬁc disease pheno-
type of CVB3. As such, it will be important to study any putative cell-
speciﬁc defects of these mutant viruses in human coronary artery
endothelial cells, primary murine heart ﬁbroblasts, and human
pancreas cells. These cells are natural targets of coxsackie B virus
infections, and they may provide an important starting point in
evaluating these mutant coxsackieviruses as potential vaccine
candidates (Chapman et al., 2000).
Materials and methods
Plasmid design and in vitro transcription
A plasmid harboring cDNA corresponding to the putative coxsack-
ievirus stem-loop IV sequences was generated by PCR ampliﬁcation of
DNA sequences (235–430), corresponding to poliovirus stem-loop IV,
from a coxsackievirus 5′ NCR-luciferase construct and cloning into a
pGEM4Z vector (Walter et al., 1999). Linearization by EcoRI digestion
followed by in vitro transcription of the plasmid generated a
coxsackievirus stem-loop IV transcript that is 205 nucleotides in
length. Radio-labeled coxsackievirus stem-loop IV RNAwas generated
by in vitro T7 polymerase (New England Biolabs) transcription using
α-32P UTP (GE Health Sciences). After transcription the RNA was
puriﬁed by Chromaspin chromatography (Clontech), phenol/chloro-
form extraction, and ethanol precipitation.
5′ end-labeling of coxsackievirus RNAs
Coxsackievirus stem-loop IV RNA was transcribed in vitro using T7
polymerase (Ambion). The 5′ phosphate of the RNA was removed
using calf intestine phosphatase (New England Biolabs). Coxsack-
ievirus stem-loop IV RNA was end-labeled with γ-32P-ATP using T4
polynucleotide kinase (New England Biolabs). The reaction products
were then resolved on an 8% polyacrylamide gel in the presence of
urea, and the RNA transcript was excised from the gel and eluted with
elution buffer (500 mM NH4OAc, 1 mM EDTA and 0.1% SDS). The
eluted RNA was subjected to phenol/chloroform extraction and
ethanol precipitation.
PCBP2 puriﬁcation
A pET22-PCBP2 plasmid was transformed into Escherichia coli BL-
21(DE3) cells. One liter of M9 media was inoculated with 1 ml of
overnight culture. The cells were grown at 37 °C until the culture
reached an absorbance of OD600=0.2. Protein expressionwas induced
by addition of 1 mM IPTG. The bacteria were grown for an additional
3 h at 18 °C and then collected by centrifugation. The bacterial pellet
was resuspended in 20 ml of phosphate buffer (50 mM phosphate pH
7.0, 5% glycerol, and 300 mM NaCl) and lysed by sonication. The
supernatant was adjusted to 20% ammonium sulfate and centrifuged
to pellet the protein precipitate. The ammonium sulfate precipitate
was resuspended in 10 ml of phosphate buffer and dialyzed overnight
against 1 L of phosphate buffer. The protein was batch bound in 1 ml
bed volume of Ni2+ Sepharose resin (Amersham). The resin was
loaded onto a column and washed with 50 ml of 20 mM imidazole-
phosphate buffer and eluted with 200 mM imidazole-phosphate
buffer. The protein was dialyzed in a modiﬁed initiation factor buffer
(5 mM Tris–Cl, 25 mM KCl, 0.5 mM DTT, 0.05 mM EDTA, and 5%
glycerol) prior to use in mobility shift assays or RNase foot-printing
assays.HeLa cell S10 preparation
HeLa S10 cytoplasmic extracts were prepared with slight
modiﬁcations following a published protocol (Barton and Flanegan,
1993). Brieﬂy, 6 L of suspension HeLa cells were collected by
centrifugation and resuspended in wash buffer (35 mM HEPES pH
7.4, 146 mM NaCl, and 11 mM glucose). After centrifugation, the
HeLa cell pellet was then resuspended in hypotonic buffer (20 mM
HEPES pH 7.4, 10 mM KCl, 1.5 mM MgOAc, and 1 mM DTT) and
allowed to swell for 20 min on ice. Cells were lysed by Dounce
homogenization, and the extract was adjusted by adding 1/10 of the
extract volume of post-lysis buffer (20 mM HEPES pH 7.4, 120 mM
KOAc, 4 mM MgOAc, and 5 mM DTT). The extract was then subjected
to centrifugation at 10,000×g for 20 min. The supernatant (S10) was
then adjusted to 1 mM CaCl2 and 20 μg/ml micrococcal nuclease,
and the mixture was incubated for 15 min at 14 °C, followed by
addition of EGTA to a ﬁnal concentration of 4 mM. The extract was
stored in liquid N2.
Electrophoretic mobility shift assays
PCBP2 proteins were pre-incubated (at a ﬁnal concentration of 50
or 100 nM) with BSA (1 mg/ml), yeast tRNA (0.8 mg/ml) and binding
buffer (5 mM HEPES pH 7.5, 25 mM KCl, 2 mM MgCl2, 0.1 mM EDTA,
2 mM DTT, and 4% glycerol) in a volume of 9 μl for 10 min at 30 °C.
Then 1 μl of radiolabeled coxsackievirus stem-loop IV RNA (at a ﬁnal
concentration of 0.1 nM or 1.0 nM) was added, and the reaction was
incubated for an additional 10 min at 30 °C. The reaction mixture was
adjusted to 10% glycerol and resolved by native polyacrylamide (4%)
gel electrophoresis in the presence of glycerol.
In vitro translation and luciferase assays
Translation reactions were carried out as described (Walter et al.,
1999). Brieﬂy, the in vitro translation mixtures consisted of 60%
HeLa S10 cytoplasmic extract, 1 μl of all-4 mix (1 mM ATP, 250 μM
CTP, 250 μM GTP, and 250 μM UTP, 16 mM HEPES pH 7.4, 60 mM
KOAc, 30 mM creatine-phosphate, and 400 μg creatine kinase),
50 fmol of PV 5′ NCR-luciferase RNA or CVB 5′ NCR-luciferase RNA
in a total volume of 10 μl. The reactions were incubated for 2.5 h at
30 °C. Translation was stopped by addition of 10 μl of passive lysis
buffer (Promega). Translation efﬁciency was determined by measur-
ing the light emission of 10 μl of the total in vitro translation
reaction in 50 μl of luciferin substrate (Promega) in a luminometer
(Berthold).
Enzymatic RNA structure probing and RNase foot-printing
The RNases used to carry out the enzymatic structure probing
were from Ambion. The dilutions of RNase used were 1:1 and 1:10
from stock. A total of 25–50 ng of end-labeled coxsackievirus stem-
loop IV RNA (5×105–1×106 cpm), 8 μg yeast tRNA, and 1× structure
probing buffer (Ambion) in a ﬁnal volume of 9 μl was heated to
68 °C for 90 s to denature the RNA, and then cooled to 37 °C for
2 min, and 25 °C for 2 min to renature the RNA. Then 1 μl of RNase
from stock (1:1 or a 1:10 dilution) was added. The 1:1 RNase
dilution reactions were incubated for 1 min at 25 °C while the
reactions with the 1:10 dilutions of RNase were incubated for 3 min.
For RNase foot-printing experiments, PCBP2 was added (at a ﬁnal
concentration of 5 μM) after the renaturation step and incubated for
10 min at 30 °C. Then the reaction was subjected to the RNase
digestion. For alkaline hydrolysis to generate an RNA ladder, a total
of 25–50 ng of end-labeled coxsackievirus stem-loop IV RNA
(5×105–1×106 cpm), 8 μg yeast tRNA, and 1× alkaline hydrolysis
buffer (200 mM NaHCO3) was heated to 95 °C for 4–6 min. The
reactions were then cooled on ice to stop hydrolysis.
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In vitro transcribed wild type and poly(G)-substituted stem-loop
IV coxsackievirus RNAs (Ambion) were transfected into HeLa cell
monolayers in 60-mm plates using 1 mg/ml DEAE-dextran and TS
buffer (137 mM NaCl, 4.4 mM KCl, 0.7 mM Na2HPO4–pH 7.45,
25 mM Tris, 0.5 mM MgCl2, and 0.68 mM CaCl2) for 30 min. The
transfected cells were overlaid with a semi-solid mixture of MEM
containing 8% newborn calf serum and 0.45% agarose. Transfected
cells were incubated at 37 °C for 3 days and then ﬁxed with
trichloroacetic acid (10%) and stained with crystal violet for plaque
analysis.
Single cycle growth analysis of mutant coxsackieviruses
HeLa cell monolayers were infected with passage two stocks of
wild type, poly(G)-loop, or poly(G)-bulge mutant coxsackieviruses at
a multiplicity of infection (MOI) of 10. The virus stock was generated
by RNA transfection experiments described above. At 2, 4, 6, or 8 h
post-infection, the infected monolayers and supernatants were
harvested and the virus was released by 5 cycles of freeze-thaw. The
virus preparation was subjected to centrifugation to pellet the cell
debris. Virus growth was determined by plaque assay on HeLa (R19)
cell monolayers. Brieﬂy, the virus preparation was serially diluted 10-
fold and adsorbed on cell monolayers for 30min at room temperature.
The cells were then overlaid with 0.45% agarose in MEM with 8%
newborn calf serum and incubated at 37 °C for 3 days. Cells were ﬁxed
with trichloroacetic acid (10%) and stained with crystal violet to
visualize plaques.
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